Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter

Journal of Immunology

Volumn 160, Issue 11, 1998, Pages 5374-5381

  Parra, Eduardo ^a   McGuire, Kathleen ^c   Hedlund, Gunnar ^a,b   Dohlsten, Mikael ^a,b,d  

^a LUND UNIVERSITY   (Sweden)

^b Pharmacia & Upjohn AB   (Sweden)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; SYNAPTOTAGMIN;

ANIMAL CELL; ARTICLE; CHO CELL; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; ONCOGENE; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD28; ANTIGENS, CD58; ANTIGENS, CD80; CHO CELLS; CRICETINAE; DRUG SYNERGISM; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-JUN; SUPERANTIGENS; T-LYMPHOCYTES; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION;

EID: 0032103002     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Samelson, L. E. 1989. Lymphocyte activation. Curr, Opin. Immunol. 2:210.
2. Janeway, C. 1989. Immunogenicity signals 1, 2, 3...and 0. Immunol. Today 10: 283.
3. Janeway, C. A., and M. Golstein. 1993. Lymphocyte activation and effector functions: the role of cell surface molecules. Curr. Opin. Immunol. 5:313.
4. Jenkins, M. K., and J. G. Johnson. 1993. Molecules involved in T-cell costimulation. Curr. Opin. Immunol. 5:367.
5. Dustin, M., M. Sanders, S. Shaw, and T. Springer. 1987. Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion. J. Exp. Med. 165:677.
6. Turcovski-Corrales, S. M., R. G. Fenton, G. Peltz, and D. D. Taub. 1995. CD28:B7 interaction promote T cell adhesion. Eur. J. Immunol. 25:3087.
7. Yiling, L., A. Granelli-Piperno, J. M. Bjorndahl, C. A. Phillips, and J. M. Trevillyan. 1992. CD28-induced T cell activation. J. Immunol. 149:24.
8. June, C. H., A. Jeffrey, A. Ledbetter, P. S. Linsley, and C. B. Thompson. 1990. Role of the CD28 receptor in T-cell activation. Immunol. Today 11:211.
9. Allison, J. P. 1994. CD28/B7 interaction in T cell activation. Curr. Opin. Immunol. 6:414.
10. Koyasu, S., T. Lawton, D. Novick, M. A. Recny, F. Siliciano, B. P. Wallner, and E. L. Reinherz. 1990. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen. Proc. Natl. Acad. Sci. USA 87:2603.
11. Bierer, B. E., S. Herrmann, and S. J. Burakoff. 1988. Interaction of CD2 with its ligand, LFA-3 in human T cell proliferation. J. Immunol. 140:3358.
12. + T lymphocytes with B7 and LFA-3 results in distinct cell activation profiles. J. Immunol. 153:2479.
13. Granelli-Piperno, A., and P. Nolan. 1991. Nuclear transcription factors that bind to elements of the IL-2 promoter. J. Immunol. 147:2734.
14. Durand, D. B., J. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, and G. R. Crabtree. 1988. Characterization of antigen receptor response elements within the interlcukin-2 enhancer. Mol Cell Biol. 8:1715.
15. + T cells with LFA-3 and B7 induce distinct effects on AP-1 and NF-κB transcription factors. J. Immunol. 155:1132.
16. Parra, E., M. Varga, G. Hedlund, T. Kalland, and M. Dohlsten. 1997. Costimulation by B7-1 and LFA-3 target distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3 induced NF-AT DNA binding. Mol. Cell. Biol. 17:1314.
17. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405.
18. Serfling, E., A. Avots, and M. Neumann. 1995. The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. Biochim. Biophvs. Acta 1263:181.
19. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
20. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-KB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723.
21. Bull, P., K. L. Morley, M. F. Hoekstra, T. Hunter, and I. M. Verma. 1990. The mouse c-rel protein has an N-terminal regulatory domain and a C terminal transcriptional transactivation domain. Mol. Cell. Biol. 10:5473.
22. Lienhard Schmitz, M., and P. A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10:3805.
23. Ruben, S. M., J. F. Klement, T. A. Coleman, M. Maher, C.-H. Chen, and C. A. Rosen. 1992. I-Rel: a novel rel-related protein that inhibits NF-κB transcriptional activity. Genes Dev. 6:745.
24. Tan, T.-H., G. P. Huang, A. Sica, P. Ghosh, H. A. Young, D. Longo, and N. R. Rice. 1992. κB site-dependent activation of the interleukin-2 receptor α-chain gene promoter by human c-rel. Mol. Cell. Biol. 12:4067.
25. Ghosh, S., A. M. Gifford, L. R. Riviere, P. Tempst, G. P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB homology to rel and dorsal. Cell 62:1019.
26. Grimm, S., and P. A. Baeuerle. 1993. The inducible transcription factor NF-κB: structure-function relationship of its protein subunits. Biochem. J. 290:297.
27. Hay, R. T. 1993. Control of nuclear factor-κB DNA binding activity by inhibitor proteins containing ankyrin repeats. Biochem. Soc. Trans. 21:926.
28. Beg, A. A., and A. S. Baldwin. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:1564.
29. Traeckner, E., H. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. 1995. Phosphorylation of human IκB-a on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14: 2876.
30. Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313.
31. Ghos, P., T. Tan, N. R. Rice, A. Sica, and H. A Young. 1993. The interleukin 2 CD28-responsive complex contains at least three members of the KB family: c-Rel, p50 and p65. Proc. Natl. Acad. Sci. USA 90:1696.
32. Lai, J-H., G. Horvath, J. Subleski, J. Bruder, P. Ghosh, and T.-H. Tan. 1955. Rel A is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Mol. Cell Biol. 15:4260.
33. Verweij, C. L., M. Geerts, and L. A. Aarden. 1991. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element. J. Biol. Chem. 266:14179.
34. Civil, A., M. Geerts, L. A. Aarden, and C. L. Verweij. 1992. Evidence for a role of CD28RE as a response element for distinct mitogenic T cell activation signal. Eur. J. Immunol. 22:3041.
35. McGuire, K., and M. lacobelli. 1997. Involvement of Rel, Fos and Jun proteins in binding activity to the interleukin 2 promoter CD28RE/AP-1 sequence in human T cells. J. Immunol. 159:1319.
36. Fraser, J. D., and A. Weiss. 1992. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28. Mol. Cell. Biol. 12:4357.
37. Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcriptional factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741.
38. Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729.
39. Angel, P., and M. Karin. 1991. The role of jun, fos and the AP-1 complex in cell-proliferation and transformation. Biochem. Biophys. Acta 1072:129.
40. Suzuki, T., H. Okuno, T. Yoshida, T. Endo, H. Nishina, and H. Iba. 1991. Difference in transcriptional regulatory function between c-fos and fra-2. Nucleic Acids Res. 19:5537.
41. Jain, J., P. G. McCaffrey, V. E. Valge-Archer, and A. Rao. 1992. Nuclear factor of activated T cells contains Fos and Jun. Nature 356:801.
42. Jain, J., P. G. McCaffrey, Z. Miner, T. K. Kerppola, J. N. Lambert, G. L. Vereine, T. Curran, and A. Rao. 1993. The T-cell transcription factor NF-ATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365:352.
43. Castigli, E., T. A. Chatila, and R. S. Geha. 1993. A protein of the AP-1 family is a component of nuclear factor of activated T cells. J. Immunol. 150:3284.
44. De Grazia, U., M. P. Felli, A. Vacca, A. R. Farina, M. Maroder, L. Cappa Bianca, D. Meco, M. Farina, I. Screpanti, L. Frati, and A. Gulino. 1994. Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2. and retinoic acid receptor. J. Exp. Med. 180:1485.
45. Stein, B., A. S. Baldwin, D. W. Ballard, W. Greene, P. Angel, and P. Herrlich. 1993. Cross-coupling of the NF-κB p65 and fos/jun transcription factors produces potentiated biological function. EMBO J. 12:3879.
46. Nolan, G. P. 1994. NF-AT-AP-1 and Rel-bZIP: hybrid vigor and binding under the influence. Cell 77:795.
47. + T cell subsets. Scand. J. Immunol. 36:243.
48. Fischer, H., G. Hedlund, T. Kalland, H. O. Sjögren, and M. Dohlsten. 1990. Independent regulation of IFN-γ and tumor necrosis factor by IL-1 in human T helper cells. J. Immunol. 145:3767.
49. Rincón, M., and R. A. Flavell. 1994. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 13:4370.
50. Curtis, V. E., R. Smilde, and K. Mcguire. 1996. Requirements for IL-2 promoter transactivation by the tax protein of human T cell leukemia virus type 1. Mol Cell Biol 16:3567.
51. Shapiro, V. S., K. E. Truitt, J. B. Imboden, and A. Weiss. 1997. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell Biol. 10:405.
52. Hues, S., H. Wakasugi, G. Sterkers, J. Gilmour, T. Tursz, I. Boumsell, and A. Bernard. 1986. T cell activation via CD2 (T, gp50): the role of accessory cells in activating resting cells via CD2. J. Immunol. 137:1420.
53. Stein, B., P. C. Cogswell, and A. S. Baldwin. Functional and physical association between NF-κB and C-EBP family members a rel domain-bZIP interaction. 1993. Mol Cell. Biol. 13:3964.
54. Grilli, M., J.-S. Jason, and M. J. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1.
55. Himes, S. R., L. S. Coles, R. Reeves, and F. Shannon. 1996. High mobility group protein I (Y) is required for function and for c-rel binding to CD28 response elements within the GM-CSF and IL-2 promoters. Immunity 5:479.
56. Sassone-Corsi, P., J. C. Sisson, and I. M. Verma. 1988. Transcriptional regulation of the proto-oncogene fos. Nature 334:314.
57. Howcroft, T. K., J. C. Richardson, and D. S. Singer. 1993. MHC class I gene expression is negatively regulated by the proto-oncogene, c-jun. EMBO J. 12: 3163.
58. Trouche, D., M. Grigoriev, J. L. Lenormand, P. Robin, S. A. Leibovitch, C. P. Sassone, and B. A. Harel. 1993. Repression of c-fos promoter by MyoD on muscle cell differentiation. Nature 363:79.
59. Bengal, E., L. Ransone, R. Scharman, V. J. Dwarki, S. J. Weintraub, and I. M. Verma. 1992. Functional antagonism between c-jun and MyoD proteins: a direct physical association. Cell 68:507.
60. Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and B. Neriah. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77: 727.